Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pediatric Vaccines Market Growth 2022-2028

  • LP 4926395
  • 120 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pediatric Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Pediatric Vaccines market size is USD million in 2022 from USD 29080 million in 2021, with a change of % between 2021 and 2022. The global Pediatric Vaccines market size will reach USD 43480 million in 2028, growing at a CAGR of 5.9% over the analysis period.

The United States Pediatric Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pediatric Vaccines market, reaching US$ million by the year 2028. As for the Europe Pediatric Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pediatric Vaccines players cover GlaxoSmithKline, Merck, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Diphtheria

Influenza

Hepatitis

Pneumococcal Diseases

Meningococcal Diseases

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Newborn

Infant

Child

Dolescent

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GlaxoSmithKline

Merck

Pfizer

Sanofi

AstraZeneca

Novartis

Takeda Pharmaceutical

Bavarian Nordic

Baxter

LG Life Sciences

Lupin

S K Chemicals

Mitsubishi Tanabe Pharma

Janssen

Shenzhen Kangtai Biological Products

Sinovac Biotech

Bharat Biotech

Crucell

Dynavax

Serum Institute of India

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pediatric Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pediatric Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pediatric Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Pediatric Vaccines Segment by Type

2.2.1 Diphtheria

2.2.2 Influenza

2.2.3 Hepatitis

2.2.4 Pneumococcal Diseases

2.2.5 Meningococcal Diseases

2.2.6 Others

2.3 Pediatric Vaccines Sales by Type

2.3.1 Global Pediatric Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Pediatric Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pediatric Vaccines Sale Price by Type (2017-2022)

2.4 Pediatric Vaccines Segment by Application

2.4.1 Newborn

2.4.2 Infant

2.4.3 Child

2.4.4 Dolescent

2.5 Pediatric Vaccines Sales by Application

2.5.1 Global Pediatric Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Pediatric Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pediatric Vaccines Sale Price by Application (2017-2022)

3 Global Pediatric Vaccines by Company

3.1 Global Pediatric Vaccines Breakdown Data by Company

3.1.1 Global Pediatric Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Pediatric Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Pediatric Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Pediatric Vaccines Revenue by Company (2020-2022)

3.2.2 Global Pediatric Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Pediatric Vaccines Sale Price by Company

3.4 Key Manufacturers Pediatric Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pediatric Vaccines Product Location Distribution

3.4.2 Players Pediatric Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pediatric Vaccines by Geographic Region

4.1 World Historic Pediatric Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Pediatric Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pediatric Vaccines Annual Revenue by Geographic Region

4.2 World Historic Pediatric Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Pediatric Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pediatric Vaccines Annual Revenue by Country/Region

4.3 Americas Pediatric Vaccines Sales Growth

4.4 APAC Pediatric Vaccines Sales Growth

4.5 Europe Pediatric Vaccines Sales Growth

4.6 Middle East & Africa Pediatric Vaccines Sales Growth

5 Americas

5.1 Americas Pediatric Vaccines Sales by Country

5.1.1 Americas Pediatric Vaccines Sales by Country (2017-2022)

5.1.2 Americas Pediatric Vaccines Revenue by Country (2017-2022)

5.2 Americas Pediatric Vaccines Sales by Type

5.3 Americas Pediatric Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pediatric Vaccines Sales by Region

6.1.1 APAC Pediatric Vaccines Sales by Region (2017-2022)

6.1.2 APAC Pediatric Vaccines Revenue by Region (2017-2022)

6.2 APAC Pediatric Vaccines Sales by Type

6.3 APAC Pediatric Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pediatric Vaccines by Country

7.1.1 Europe Pediatric Vaccines Sales by Country (2017-2022)

7.1.2 Europe Pediatric Vaccines Revenue by Country (2017-2022)

7.2 Europe Pediatric Vaccines Sales by Type

7.3 Europe Pediatric Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pediatric Vaccines by Country

8.1.1 Middle East & Africa Pediatric Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pediatric Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Pediatric Vaccines Sales by Type

8.3 Middle East & Africa Pediatric Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pediatric Vaccines

10.3 Manufacturing Process Analysis of Pediatric Vaccines

10.4 Industry Chain Structure of Pediatric Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pediatric Vaccines Distributors

11.3 Pediatric Vaccines Customer

12 World Forecast Review for Pediatric Vaccines by Geographic Region

12.1 Global Pediatric Vaccines Market Size Forecast by Region

12.1.1 Global Pediatric Vaccines Forecast by Region (2023-2028)

12.1.2 Global Pediatric Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pediatric Vaccines Forecast by Type

12.7 Global Pediatric Vaccines Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline Pediatric Vaccines Product Offered

13.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Pediatric Vaccines Product Offered

13.2.3 Merck Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Pediatric Vaccines Product Offered

13.3.3 Pfizer Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Sanofi

13.4.1 Sanofi Company Information

13.4.2 Sanofi Pediatric Vaccines Product Offered

13.4.3 Sanofi Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi Main Business Overview

13.4.5 Sanofi Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Pediatric Vaccines Product Offered

13.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Pediatric Vaccines Product Offered

13.6.3 Novartis Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 Takeda Pharmaceutical

13.7.1 Takeda Pharmaceutical Company Information

13.7.2 Takeda Pharmaceutical Pediatric Vaccines Product Offered

13.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Takeda Pharmaceutical Main Business Overview

13.7.5 Takeda Pharmaceutical Latest Developments

13.8 Bavarian Nordic

13.8.1 Bavarian Nordic Company Information

13.8.2 Bavarian Nordic Pediatric Vaccines Product Offered

13.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bavarian Nordic Main Business Overview

13.8.5 Bavarian Nordic Latest Developments

13.9 Baxter

13.9.1 Baxter Company Information

13.9.2 Baxter Pediatric Vaccines Product Offered

13.9.3 Baxter Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Baxter Main Business Overview

13.9.5 Baxter Latest Developments

13.10 LG Life Sciences

13.10.1 LG Life Sciences Company Information

13.10.2 LG Life Sciences Pediatric Vaccines Product Offered

13.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 LG Life Sciences Main Business Overview

13.10.5 LG Life Sciences Latest Developments

13.11 Lupin

13.11.1 Lupin Company Information

13.11.2 Lupin Pediatric Vaccines Product Offered

13.11.3 Lupin Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Lupin Main Business Overview

13.11.5 Lupin Latest Developments

13.12 S K Chemicals

13.12.1 S K Chemicals Company Information

13.12.2 S K Chemicals Pediatric Vaccines Product Offered

13.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 S K Chemicals Main Business Overview

13.12.5 S K Chemicals Latest Developments

13.13 Mitsubishi Tanabe Pharma

13.13.1 Mitsubishi Tanabe Pharma Company Information

13.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Offered

13.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Mitsubishi Tanabe Pharma Main Business Overview

13.13.5 Mitsubishi Tanabe Pharma Latest Developments

13.14 Janssen

13.14.1 Janssen Company Information

13.14.2 Janssen Pediatric Vaccines Product Offered

13.14.3 Janssen Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Janssen Main Business Overview

13.14.5 Janssen Latest Developments

13.15 Shenzhen Kangtai Biological Products

13.15.1 Shenzhen Kangtai Biological Products Company Information

13.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Offered

13.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Shenzhen Kangtai Biological Products Main Business Overview

13.15.5 Shenzhen Kangtai Biological Products Latest Developments

13.16 Sinovac Biotech

13.16.1 Sinovac Biotech Company Information

13.16.2 Sinovac Biotech Pediatric Vaccines Product Offered

13.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sinovac Biotech Main Business Overview

13.16.5 Sinovac Biotech Latest Developments

13.17 Bharat Biotech

13.17.1 Bharat Biotech Company Information

13.17.2 Bharat Biotech Pediatric Vaccines Product Offered

13.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Bharat Biotech Main Business Overview

13.17.5 Bharat Biotech Latest Developments

13.18 Crucell

13.18.1 Crucell Company Information

13.18.2 Crucell Pediatric Vaccines Product Offered

13.18.3 Crucell Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Crucell Main Business Overview

13.18.5 Crucell Latest Developments

13.19 Dynavax

13.19.1 Dynavax Company Information

13.19.2 Dynavax Pediatric Vaccines Product Offered

13.19.3 Dynavax Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Dynavax Main Business Overview

13.19.5 Dynavax Latest Developments

13.20 Serum Institute of India

13.20.1 Serum Institute of India Company Information

13.20.2 Serum Institute of India Pediatric Vaccines Product Offered

13.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Serum Institute of India Main Business Overview

13.20.5 Serum Institute of India Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pediatric Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pediatric Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Diphtheria

Table 4. Major Players of Influenza

Table 5. Major Players of Hepatitis

Table 6. Major Players of Pneumococcal Diseases

Table 7. Major Players of Meningococcal Diseases

Table 8. Major Players of Others

Table 9. Global Pediatric Vaccines Sales by Type (2017-2022) & (K Units)

Table 10. Global Pediatric Vaccines Sales Market Share by Type (2017-2022)

Table 11. Global Pediatric Vaccines Revenue by Type (2017-2022) & ($ million)

Table 12. Global Pediatric Vaccines Revenue Market Share by Type (2017-2022)

Table 13. Global Pediatric Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global Pediatric Vaccines Sales by Application (2017-2022) & (K Units)

Table 15. Global Pediatric Vaccines Sales Market Share by Application (2017-2022)

Table 16. Global Pediatric Vaccines Revenue by Application (2017-2022)

Table 17. Global Pediatric Vaccines Revenue Market Share by Application (2017-2022)

Table 18. Global Pediatric Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global Pediatric Vaccines Sales by Company (2020-2022) & (K Units)

Table 20. Global Pediatric Vaccines Sales Market Share by Company (2020-2022)

Table 21. Global Pediatric Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Pediatric Vaccines Revenue Market Share by Company (2020-2022)

Table 23. Global Pediatric Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers Pediatric Vaccines Producing Area Distribution and Sales Area

Table 25. Players Pediatric Vaccines Products Offered

Table 26. Pediatric Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Pediatric Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Pediatric Vaccines Sales Market Share Geographic Region (2017-2022)

Table 31. Global Pediatric Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Pediatric Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Pediatric Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Pediatric Vaccines Sales Market Share by Country/Region (2017-2022)

Table 35. Global Pediatric Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Pediatric Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Pediatric Vaccines Sales by Country (2017-2022) & (K Units)

Table 38. Americas Pediatric Vaccines Sales Market Share by Country (2017-2022)

Table 39. Americas Pediatric Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Pediatric Vaccines Revenue Market Share by Country (2017-2022)

Table 41. Americas Pediatric Vaccines Sales by Type (2017-2022) & (K Units)

Table 42. Americas Pediatric Vaccines Sales Market Share by Type (2017-2022)

Table 43. Americas Pediatric Vaccines Sales by Application (2017-2022) & (K Units)

Table 44. Americas Pediatric Vaccines Sales Market Share by Application (2017-2022)

Table 45. APAC Pediatric Vaccines Sales by Region (2017-2022) & (K Units)

Table 46. APAC Pediatric Vaccines Sales Market Share by Region (2017-2022)

Table 47. APAC Pediatric Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Pediatric Vaccines Revenue Market Share by Region (2017-2022)

Table 49. APAC Pediatric Vaccines Sales by Type (2017-2022) & (K Units)

Table 50. APAC Pediatric Vaccines Sales Market Share by Type (2017-2022)

Table 51. APAC Pediatric Vaccines Sales by Application (2017-2022) & (K Units)

Table 52. APAC Pediatric Vaccines Sales Market Share by Application (2017-2022)

Table 53. Europe Pediatric Vaccines Sales by Country (2017-2022) & (K Units)

Table 54. Europe Pediatric Vaccines Sales Market Share by Country (2017-2022)

Table 55. Europe Pediatric Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Pediatric Vaccines Revenue Market Share by Country (2017-2022)

Table 57. Europe Pediatric Vaccines Sales by Type (2017-2022) & (K Units)

Table 58. Europe Pediatric Vaccines Sales Market Share by Type (2017-2022)

Table 59. Europe Pediatric Vaccines Sales by Application (2017-2022) & (K Units)

Table 60. Europe Pediatric Vaccines Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Pediatric Vaccines Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Pediatric Vaccines Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Pediatric Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Pediatric Vaccines Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Pediatric Vaccines Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Pediatric Vaccines Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Pediatric Vaccines Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Pediatric Vaccines Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Pediatric Vaccines

Table 70. Key Market Challenges & Risks of Pediatric Vaccines

Table 71. Key Industry Trends of Pediatric Vaccines

Table 72. Pediatric Vaccines Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Pediatric Vaccines Distributors List

Table 75. Pediatric Vaccines Customer List

Table 76. Global Pediatric Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Pediatric Vaccines Sales Market Forecast by Region

Table 78. Global Pediatric Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Pediatric Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Pediatric Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Pediatric Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Pediatric Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Pediatric Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Pediatric Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Pediatric Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Pediatric Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Pediatric Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Pediatric Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Pediatric Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Pediatric Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Pediatric Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Pediatric Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Pediatric Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Pediatric Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Pediatric Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 96. GlaxoSmithKline Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 97. GlaxoSmithKline Pediatric Vaccines Product Offered

Table 98. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. GlaxoSmithKline Main Business

Table 100. GlaxoSmithKline Latest Developments

Table 101. Merck Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 102. Merck Pediatric Vaccines Product Offered

Table 103. Merck Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Merck Main Business

Table 105. Merck Latest Developments

Table 106. Pfizer Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 107. Pfizer Pediatric Vaccines Product Offered

Table 108. Pfizer Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. Pfizer Main Business

Table 110. Pfizer Latest Developments

Table 111. Sanofi Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 112. Sanofi Pediatric Vaccines Product Offered

Table 113. Sanofi Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 114. Sanofi Main Business

Table 115. Sanofi Latest Developments

Table 116. AstraZeneca Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 117. AstraZeneca Pediatric Vaccines Product Offered

Table 118. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 119. AstraZeneca Main Business

Table 120. AstraZeneca Latest Developments

Table 121. Novartis Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 122. Novartis Pediatric Vaccines Product Offered

Table 123. Novartis Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 124. Novartis Main Business

Table 125. Novartis Latest Developments

Table 126. Takeda Pharmaceutical Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 127. Takeda Pharmaceutical Pediatric Vaccines Product Offered

Table 128. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 129. Takeda Pharmaceutical Main Business

Table 130. Takeda Pharmaceutical Latest Developments

Table 131. Bavarian Nordic Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 132. Bavarian Nordic Pediatric Vaccines Product Offered

Table 133. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 134. Bavarian Nordic Main Business

Table 135. Bavarian Nordic Latest Developments

Table 136. Baxter Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 137. Baxter Pediatric Vaccines Product Offered

Table 138. Baxter Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 139. Baxter Main Business

Table 140. Baxter Latest Developments

Table 141. LG Life Sciences Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 142. LG Life Sciences Pediatric Vaccines Product Offered

Table 143. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 144. LG Life Sciences Main Business

Table 145. LG Life Sciences Latest Developments

Table 146. Lupin Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 147. Lupin Pediatric Vaccines Product Offered

Table 148. Lupin Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 149. Lupin Main Business

Table 150. Lupin Latest Developments

Table 151. S K Chemicals Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 152. S K Chemicals Pediatric Vaccines Product Offered

Table 153. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 154. S K Chemicals Main Business

Table 155. S K Chemicals Latest Developments

Table 156. Mitsubishi Tanabe Pharma Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 157. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Offered

Table 158. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 159. Mitsubishi Tanabe Pharma Main Business

Table 160. Mitsubishi Tanabe Pharma Latest Developments

Table 161. Janssen Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 162. Janssen Pediatric Vaccines Product Offered

Table 163. Janssen Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 164. Janssen Main Business

Table 165. Janssen Latest Developments

Table 166. Shenzhen Kangtai Biological Products Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 167. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Offered

Table 168. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 169. Shenzhen Kangtai Biological Products Main Business

Table 170. Shenzhen Kangtai Biological Products Latest Developments

Table 171. Sinovac Biotech Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 172. Sinovac Biotech Pediatric Vaccines Product Offered

Table 173. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 174. Sinovac Biotech Main Business

Table 175. Sinovac Biotech Latest Developments

Table 176. Bharat Biotech Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 177. Bharat Biotech Pediatric Vaccines Product Offered

Table 178. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 179. Bharat Biotech Main Business

Table 180. Bharat Biotech Latest Developments

Table 181. Crucell Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 182. Crucell Pediatric Vaccines Product Offered

Table 183. Crucell Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 184. Crucell Main Business

Table 185. Crucell Latest Developments

Table 186. Dynavax Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 187. Dynavax Pediatric Vaccines Product Offered

Table 188. Dynavax Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 189. Dynavax Main Business

Table 190. Dynavax Latest Developments

Table 191. Serum Institute of India Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 192. Serum Institute of India Pediatric Vaccines Product Offered

Table 193. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 194. Serum Institute of India Main Business

Table 195. Serum Institute of India Latest Developments

List of Figures

Figure 1. Picture of Pediatric Vaccines

Figure 2. Pediatric Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pediatric Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pediatric Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pediatric Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Diphtheria

Figure 10. Product Picture of Influenza

Figure 11. Product Picture of Hepatitis

Figure 12. Product Picture of Pneumococcal Diseases

Figure 13. Product Picture of Meningococcal Diseases

Figure 14. Product Picture of Others

Figure 15. Global Pediatric Vaccines Sales Market Share by Type in 2021

Figure 16. Global Pediatric Vaccines Revenue Market Share by Type (2017-2022)

Figure 17. Pediatric Vaccines Consumed in Newborn

Figure 18. Global Pediatric Vaccines Market: Newborn (2017-2022) & (K Units)

Figure 19. Pediatric Vaccines Consumed in Infant

Figure 20. Global Pediatric Vaccines Market: Infant (2017-2022) & (K Units)

Figure 21. Pediatric Vaccines Consumed in Child

Figure 22. Global Pediatric Vaccines Market: Child (2017-2022) & (K Units)

Figure 23. Pediatric Vaccines Consumed in Dolescent

Figure 24. Global Pediatric Vaccines Market: Dolescent (2017-2022) & (K Units)

Figure 25. Global Pediatric Vaccines Sales Market Share by Application (2017-2022)

Figure 26. Global Pediatric Vaccines Revenue Market Share by Application in 2021

Figure 27. Pediatric Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Pediatric Vaccines Revenue Market Share by Company in 2021

Figure 29. Global Pediatric Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Pediatric Vaccines Revenue Market Share by Geographic Region in 2021

Figure 31. Global Pediatric Vaccines Sales Market Share by Region (2017-2022)

Figure 32. Global Pediatric Vaccines Revenue Market Share by Country/Region in 2021

Figure 33. Americas Pediatric Vaccines Sales 2017-2022 (K Units)

Figure 34. Americas Pediatric Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. APAC Pediatric Vaccines Sales 2017-2022 (K Units)

Figure 36. APAC Pediatric Vaccines Revenue 2017-2022 ($ Millions)

Figure 37. Europe Pediatric Vaccines Sales 2017-2022 (K Units)

Figure 38. Europe Pediatric Vaccines Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Pediatric Vaccines Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Pediatric Vaccines Revenue 2017-2022 ($ Millions)

Figure 41. Americas Pediatric Vaccines Sales Market Share by Country in 2021

Figure 42. Americas Pediatric Vaccines Revenue Market Share by Country in 2021

Figure 43. United States Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Pediatric Vaccines Sales Market Share by Region in 2021

Figure 48. APAC Pediatric Vaccines Revenue Market Share by Regions in 2021

Figure 49. China Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Pediatric Vaccines Sales Market Share by Country in 2021

Figure 56. Europe Pediatric Vaccines Revenue Market Share by Country in 2021

Figure 57. Germany Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Pediatric Vaccines Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Pediatric Vaccines Revenue Market Share by Country in 2021

Figure 64. Egypt Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Pediatric Vaccines in 2021

Figure 70. Manufacturing Process Analysis of Pediatric Vaccines

Figure 71. Industry Chain Structure of Pediatric Vaccines

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390